BiotechCorp is organising a townhall session on 25 February 2014 for BioNexus Status companies at Hotel Istana, Kuala Lumpur. The townhall session will be chaired by YBhg. Dato’ Dr. Mohd Nazlee Kamal, CEO of BiotechCorp. The aim of the session is to provide an overview of the Government’s latest plans and initiatives under the National Biotechnology Policy and the Bioeconomy Transformation Programme (BTP). This is a platform for the BioNexus companies to discuss and directly engage with BiotechCorp’s team in relation to the latest developments on the projects that will be carried out under the Bioeconomy Malaysia plan.

The townhall session will be followed by the BioNexus Funding Seminar on 25-26 February 2014. This event is initiated by BiotechCorp with the support of various financial institutions and agencies offering developmental funds and programmes. The objective of this seminar is to disseminate information regarding the various funding options and developmental programmes available to BioNexus companies.

Information on BioNexus Status

BioNexus is a special status awarded to qualified international and Malaysian biotechnology companies. The status endows fiscal incentives, grants and other guarantees to assist growth. This status is awarded to qualified companies undertaking value-added biotechnology and/or life sciences activities. Apart from the overall benefits and support, BioNexus companies are assured a list of privileges as stipulated in the BioNexus Bill of Guarantees.

For more information on the event and BioNexus Status, please contact:

Nora Mohamed
Vice President, Industry Support
BioNexus Development Division
Tel: 03-2116 5588
Email:nora.mohamed@biotechcorp.com.my